SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037425
Filing Date
2022-11-10
Accepted
2022-11-10 17:04:42
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-10q_20220930.htm   iXBRL 10-Q 2484734
2 EX-10.1 etnb-ex101_12.htm EX-10.1 25324
3 EX-31.1 etnb-ex311_7.htm EX-31.1 20143
4 EX-31.2 etnb-ex312_6.htm EX-31.2 20156
5 EX-32 etnb-ex32_8.htm EX-32 15947
  Complete submission text file 0001564590-22-037425.txt   8338102

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA etnb-20220930.xsd EX-101.SCH 48561
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etnb-20220930_cal.xml EX-101.CAL 53056
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20220930_def.xml EX-101.DEF 165125
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20220930_lab.xml EX-101.LAB 414900
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20220930_pre.xml EX-101.PRE 300498
55 EXTRACTED XBRL INSTANCE DOCUMENT etnb-10q_20220930_htm.xml XML 1539868
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 221378374
SIC: 2834 Pharmaceutical Preparations